Robert B Chao, MD
Tweet
Extended 5 year study of secukinumab in AS patients showed sustained improvement of back pain, nocturnal back pain, AM stiffness, fatigue and LDA Abs#0364 @RheumNow #ACR20
All News
Dr. Rachel Tate
Tweet
PsA pts have ^ risk of developing polyclonal gammopathy, MGUS, and possibly progression to lymphoproliferative malignancy. #ABS0338 #ACR20 @RheumNow https://t.co/jl6sq1KcKZ https://t.co/BHrGKPXs3a
k dao
Tweet
#GREATDEBATE Dr. Weinblatt won - but based on the limited # people polled d/t difficulties with website #ACR20 @RheumNow
Dr. Rachel Tate
Tweet
Do you screen your PsA patients for lymphoproliferative disease? @RheumNow #ACR20 #ABS0338
k dao
Tweet
Dr. G Gilkeson #Klempererlecture #ACR20 @rheumnow
There is a lupus gradient b/t Africa and US: we are seeing more SLE in the US (genetics? environmental? diet?)
Dr. Rachel Tate
Tweet
The Great Debate results! https://t.co/tJk0yIRqfK
Dr. Rachel Tate
Tweet
Since you’ve just listened to The Great Debate, what do you use as your first line therapy in RA #ACR20? @RheumNow
sheila
Tweet
MTX & liver fibrosis:
71% pts w/low FIB-4i of<1.45
No correlation bet FIB-4 values & cumulative MTX dose
Cumulative MTX dose not sig. ⬆ in pts with FIB-4i >1.45 @RheumNow #ACR20 Abstr#0205 https://t.co/RmyAz9M5fw
Dr. John Cush
Tweet
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by BMS, @HorizonNews , @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.
David Liew
Tweet
How well do your RA patients sleep? Is OSA an issue?
Validated questionnaires and clinician questioning missed two-thirds (23/35) of mod-severe OSA, no clues from steroid use or RA disease activity.
Should we be screening more patients?
@UCSFHospitals #ACR20 ABST0196 @RheumNow https://t.co/kibwDPYYn9
Meral K. El Ramahi, MD
Tweet
Abst#0138 at #ACR20 shows the importance of identifying alignments & discordances in perceptions of RA tx between providers & patients, individualizing txs accordingly, & a need to engage in shared-decision making to optimize RA care. @RheumNow https://t.co/dTj0S7Zm5x
Eric Dein
Tweet
Dr. Gilkerson in 2F010- Lupus in Unusual Places at #ACR20- Is it environmental or genetics that explain differences between African and African-Amer populations? Study the population (Sierra Leone), but do so with cultural sensitivity. @RheumNow https://t.co/B1ikkQgCuk
Bella Mehta
Tweet
How would you change csDMARDS and bDMARDS a few days before vaccination - if/when #COVID19 KILLED vaccine comes in (Assuming live vaccine would need strict medication management.) #ACR20 @RheumNow
David Liew
Tweet
DVT/PE has been the sticking point for baricitinib in RA.
DVT/PE risk in integrated safety analysis >8y: incidence doesn't increase, but also doesn't decrease. No diff with dose either.
Every drug has pros/cons; it's how we manage risk that counts...
#ACR20 ABST0202 @RheumNow https://t.co/V88tQjcXSJ
Julio Gonzalez
Tweet
"Anatomy of the enthesis"
#SpA #ACR20 https://t.co/uUeCWGXqtw
Janet Pope
Tweet
Do you routinely use septra/bactrim in SLE to prevent PCP/PJP? @RheumNow @CRASCRRheum
sheila
Tweet
Tips for assessing enthesial thickening by ultrasound:
- check the contralateral side
- convex appearance
@RheumNow #ACR20 #mskus https://t.co/kvburcX4Ju
Dr. Rachel Tate
Tweet
Dr. C. Bakewell reminds us that entheses can show inflammation and chronic changes. Pearl: Be sure to look at MSUS of the digits for enthesitis. #ACR20 #ACRbest @RheumNow https://t.co/D3nLGGv4ko
David Liew
Tweet
We've been taught that relapsing polychondritis ear chondritis is classically limited to the pinna.
Not true - and great collaboration from clinicians/patients to understand this better!
@maferradastrong @petercgrayson @NIH_NIAMS @RP_Organization #ACR20 ABST0423 @RheumNow https://t.co/RaqL1qirFk
Bella Mehta
Tweet
Data from the #ACR #RISE registry- 83,000 patients. Significant disparities in RA functional scores in Low SES, and got worse over time. ABS#0046 @RheumNow #ACR20 https://t.co/rcVb1gU250
